Magliani W - Search Results

1

Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?

Casadevall A, Cassone A, Bistoni F, Cutler JE, Magliani W, Murphy JW, Polonelli L, Romani L. Casadevall A, et al. Among authors: magliani w. Med Mycol. 1998;36 Suppl 1:95-105. Med Mycol. 1998. PMID: 9988497 Review.

2

The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.

Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G. Polonelli L, et al. Among authors: magliani w. Med Mycol. 2000;38 Suppl 1:281-92. Med Mycol. 2000. PMID: 11204156 Review.

3

Antibody-mediated protective immunity in fungal infections.

Magliani W, Conti S, Arseni S, Salati A, Ravanetti L, Maffei DL, Giovati L, Polonelli L. Magliani W, et al. New Microbiol. 2005 Oct;28(4):299-309. New Microbiol. 2005. PMID: 16386014 Review.

4

New immunotherapeutic strategies to control vaginal candidiasis.

Magliani W, Conti S, Cassone A, De Bernardis F, Polonelli L. Magliani W, et al. Trends Mol Med. 2002 Mar;8(3):121-6. doi: 10.1016/s1471-4914(01)02268-7. Trends Mol Med. 2002. PMID: 11879772 Review.

5

A synthetic peptide as a novel anticryptococcal agent.

Cenci E, Bistoni F, Mencacci A, Perito S, Magliani W, Conti S, Polonelli L, Vecchiarelli A. Cenci E, et al. Among authors: magliani w. Cell Microbiol. 2004 Oct;6(10):953-61. doi: 10.1111/j.1462-5822.2004.00413.x. Cell Microbiol. 2004. PMID: 15339270

6

Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.

Polonelli L, De Bernardis F, Conti S, Boccanera M, Gerloni M, Morace G, Magliani W, Chezzi C, Cassone A. Polonelli L, et al. Among authors: magliani w. J Immunol. 1994 Mar 15;152(6):3175-82. J Immunol. 1994. PMID: 8144911

7

Human natural yeast killer toxin-like candidacidal antibodies.

Polonelli L, De Bernadis F, Conti S, Boccanera M, Magliani W, Gerloni M, Cantelli C, Cassone A. Polonelli L, et al. Among authors: magliani w. J Immunol. 1996 Mar 1;156(5):1880-5. J Immunol. 1996. PMID: 8596040

8

Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.

Magliani W, Conti S, de Bernardis F, Gerloni M, Bertolotti D, Mozzoni P, Cassone A, Polonelli L. Magliani W, et al. Nat Biotechnol. 1997 Feb;15(2):155-8. doi: 10.1038/nbt0297-155. Nat Biotechnol. 1997. PMID: 9035141

9

Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria.

Beninati C, Oggioni MR, Boccanera M, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L. Beninati C, et al. Among authors: magliani w. Nat Biotechnol. 2000 Oct;18(10):1060-4. doi: 10.1038/80250. Nat Biotechnol. 2000. PMID: 11017043

10

Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody.

Oggioni MR, Beninati C, Boccanera M, Medaglini D, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L. Oggioni MR, et al. Among authors: magliani w. Int Rev Immunol. 2001;20(2):275-87. doi: 10.3109/08830180109043039. Int Rev Immunol. 2001. PMID: 11878770 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters